What: American Conference Institute’s FDA Boot Camp. Basic training in core regulatory concepts for life sciences lawyers, business executives and policy analysts. The approval process…pre-approval concerns…product labeling… clinical trials…adverse events reports… patent concerns… exclusivity. — all are critical aspects in the commercialization process for drugs, biologics, and devices which are governed by FDA law and regulation. […]
At American Conference Institute’s 17th Advanced Forum on Life Sciences Collaborative Agreements and Acquisitions, a seasoned faculty of business development, licensing, and alliance management executives from top life sciences companies like Pfizer, AstaZeneca, GlaxoSmithKline, Sanofi Pasteur, Novartis, and Bayer will help you enable your company to advance its key growth strategies. In just two days, these experienced professionals will share: In-depth analysis of […]
The Comprehensive Guide to Patent Reform Who: Patent practitioners needing a reminded how the world has changed What: The critical industry forum on The Leahy-Smith America Invents Act When: Wednesday, January 23 to Thursday, January 24, 2013 […]
What: “Effective and Practical Strategies for Prosecuting and Litigating Biotech Patents in an Increasingly Uncertain Legal Environment” American Conference Institute’s 14th Advanced Forum on Biotech Patents The ongoing implementation of the America Invents Act and a massive upheaval of subject matter patentability signal that this continues to be a period of intense uncertainty for the biotechnology […]
What: Known by many names within the industry – non-practicing entity (NPE), patent assertion entity (PAE) and most infamously as “patent trolls” – NPEs over the past few years have single-handedly spawned a sub-specialty of patent litigation. It’s certainly big business. It’s estimated that the average patent suit involving NPEs results in $122 million in […]
6th Annual Paragraph IV Disputes Expert Insights on Hatch-Waxman Litigation Strategies for Brand Names and Generics April 24-25, 2012 Workshops: April 23 and 26, 2012 Marriott New York Downtown New York City Each spring, leading pharmaceutical patent litigators for brand name and generic drug companies gather in New York City at American Conference Institute’s (ACI’s) […]
What: The only event where the industry leaders driving the business of biosimilars come together to set the standards shaping the rapidly evolving legal and regulatory landscape. Whether you are on the branded or generic side, you cannot afford to miss this opportunity because you will: Hear directly from the FDA on how they will […]
What: American Conference Institute’s FDA Boot Camp. Basic training in core regulatory concepts for life sciences lawyers, business executives and policy analysts The approval process…pre-approval concerns…product labeling…clinical trials…adverse events reports…patent concerns…exclusivity. — all are critical aspects in the commercialization process for drugs, biologics, and devices which are governed by FDA law and regulation. Recent court […]
Served Up Daily
Editor-in-Chief Barista Stephen Jenei is a patent attorney and Owner of Jenei LLC. When not serving up patent chat over a steaming cup of java, he's handling a diverse intellectual property practice in the biotechnology, pharmaceutical and chemical fields. More info @ Jenei LLC
